메뉴 건너뛰기




Volumn 10, Issue 1, 2003, Pages 41-49

Lessons learned from the irinotecan metabolic pathway

Author keywords

Carboxylesterase; CPT 11; Drug interactions and metabolism; Irinotecan; Polymorphism; Transporters; UTG1A1

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 9 AMINOCAMPTOTHECIN; ABC TRANSPORTER; ANTICONVULSIVE AGENT; ANTISENSE OLIGONUCLEOTIDE; CAMPTOTHECIN DERIVATIVE; CARBOXYLESTERASE; COMPLEMENTARY DNA; CORTICOSTEROID; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; DRUG METABOLITE; ELACRIDAR; GLUCURONOSYLTRANSFERASE; GLYCOPROTEIN P; HYPERICUM PERFORATUM EXTRACT; IRINOTECAN; KETOCONAZOLE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PRODRUG; PROTEIN INHIBITOR; TOPOTECAN; TUMOR PROTEIN;

EID: 0037238805     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033368619     Document Type: Review
Times cited : (116)

References (111)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.